Mol Cell Biol, May 1998, p. 2431-2443, Vol. 18, No. 5
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Department of Microbiology1 and Regional Primate Research Center,2 University of Washington, Seattle, Washington 98195
Received 21 August 1997/Returned for modification 16 October 1997/Accepted 22 January 1998
The interferon (IFN)-induced, double-stranded RNA-activated protein
kinase (PKR) mediates the antiviral and antiproliferative actions of
IFN, in part, via its translational inhibitory properties. Previous
studies have demonstrated that PKR forms dimers and that dimerization
is likely to be required for activation and/or function. In the present
study we used multiple approaches to examine the modulation of PKR
dimerization. Deletion analysis with the
repressor fusion system
identified a previously unrecognized site involved in PKR dimerization.
This site comprised amino acids (aa) 244 to 296, which span part of the
third basic region of PKR and the catalytic subdomains I and II. Using
the yeast two-hybrid system and far-Western analysis, we verified the
importance of this region for dimerization. Furthermore, coexpression
of the 52-aa region alone inhibited the formation of full-length PKR
dimers in the
repressor fusion and two-hybrid systems. Importantly,
coexpression of aa 244 to 296 exerted a dominant-negative effect on
wild-type kinase activity in a functional assay. Due to its role as a
mediator of IFN-induced antiviral resistance, PKR is a target of viral and cellular inhibitors. Curiously, PKR aa 244 to 296 contain the
binding site for a select group of specific inhibitors, including the
cellular protein P58IPK. We demonstrated, utilizing both
the yeast and
systems, that P58IPK, a member of the
tetratricopeptide repeat protein family, can block kinase activity by
preventing PKR dimerization. In contrast, a nonfunctional form of
P58IPK lacking a TPR motif did not inhibit kinase activity
or perturb PKR dimers. These results highlight a potential mechanism of
PKR inhibition and define a novel class of PKR inhibitors. Finally, the
data document the first known example of inhibition of protein kinase
dimerization by a cellular protein inhibitor. On the basis of these
results we propose a model for the regulation of PKR dimerization.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|